Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for refractory migraine in patients with right-to-left shunt
NCT02518464Phase 4Completed
- Sponsor
- Columbia University
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in migraine, sponsored by Columbia University. Primary endpoint: Total Number of Responders at 1 month. Started Oct 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02518464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518464.